Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Project Team Leader and management of broad spectrum antiviral drug discovery
and development programs
Lead author on SBIR NIH grants, peer reviewed manuscripts, pharm/tox, clinical
and CMC section of IND filings, patent applications, research posters, marketing
materials and press releases
Designed and presented infectious disease and oncology research program
summaries to pharmaceutical and biotech companies for new business partnerships
and licensing opportunities
Represented the company at national and international infectious disease
conferences and presented antiviral research programs
Established and maintained collaborative relationships with national and
international infectious disease KOLs and potential business partners
Expanded the companys Intellectual Property portfolio in HIV and human and
avian influenza with application to therapeutic treatment of infected patients
Lead author on press release, IND filings, SBIR NIH grants, peer reviewed
manuscripts, patent applications and research program summaries
Designed, supervised and interpreted screening, efficacy and mechanistic antiviral
studies for therapeutics to HIV, human and avian influenza, HCV, WNV and
rhinovirus
Design and monitoring of outsourced pharmacology and toxicology for antiviral
and oncology drug candidates
Design, supervision, execution and interpretation of screening, efficacy and
mechanistic antiviral studies on small molecule therapeutics for HIV, human and
avian influenza, west nile virus and herpes simplex virus
Developed assays for higher throughput screening and efficacy studies of antiviral
drug candidates
Implemented and supervised BSL-2 and BSL-3 and trained all personnel
Immusol (April 2000 - April 2004)
Senior Scientist
Developed and established combinatorial ribozyme libraries and identified novel
therapeutic drug targets for HIV, HCV and rhinovirus
Validated drug targets and identified diverse affected steps in the viral replication
cycle using siRNA technology